Complement and microglia mediate early synapse loss in Alzheimer mouse models
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index; 21 of the 28 sources its claims cite were checked for support.
Abstract
Too much cleaning up: The complement system and microglia seek out and destroy unwanted cellular debris for the peripheral immune system as well as excess synapses in the developing brain. Hong et al. now show how the system may go haywire in adults early in the progression toward Alzheimer's disease (AD). Aberrant synapse loss is an early feature of Alzheimer's and correlates with cognitive decline. In mice susceptible to AD, complement was associated with synapses, and microglial function was required for synapse loss. The authors speculate that aberrant activation of this “trash disposal” system underlies AD pathology. Science , this issue p. 712
Overview
CoChat Summary
TL;DR
In Alzheimer mouse models, classical complement proteins C1q and C3 increase and localize to synapses before plaques, and blocking C1q, C3, or microglial CR3 reduces early synapse loss. Soluble Aβ oligomers drive microglial engulfment of synaptic material through a CR3-dependent pathway, suggesting reactivation of developmental synaptic pruning in early AD.
Key findings
- J20 hAPP mice showed significant hippocampal synapse loss at 3–4 months, before plaque deposition; loss occurred in CA1, CA3, and dentate gyrus at 3 months but not in striatum, and was not seen at 1 month.
- C1q was elevated in J20 brains as early as 1 month, region-specifically in hippocampus and frontal cortex, and colocalized with PSD95-positive puncta; Compound E reduced soluble Aβ and C1q deposition, while oligomeric Aβ—but not monomeric Aβ or vehicle—induced C1q deposition and synaptic colocalization.
- Oligomeric Aβ induced synapse loss within 72 h in WT mice but not in C1qa knockout mice; anti-C1q antibody ANX-M1 prevented oAβ-induced synapse loss and LTP impairment, and APP/PS1xC3 KO mice did not show the synapse loss seen in 4-month APP/PS1 hippocampus.
- Microglial CD68 increased in J20 hippocampus and after oAβ; oAβ increased internalized Homer-GFP in microglia, failed to do so in CR3 KO mice, and induced hippocampal synapse loss in WT but not CR3 KO mice.
Methods
- Mouse models included J20 hAPP, APP/PS1, C1qa KO, C3 KO, CR3 KO, and Homer-GFP mice, with WT littermates and ages including 1 month, 3–4 months, and P21.
- Synapse quantification used super-resolution structured illumination microscopy, confocal imaging, and electron microscopy with colocalized pre- and postsynaptic puncta markers including synaptophysin/PSD95, synaptotagmin/homer, and synapsin/PSD95; C1q and C3 colocalization with PSD95 was also measured.
- Interventions included Compound E, intracerebroventricular or tail vein injections of soluble Aβ oligomers, monomers, or vehicle, anti-C1q antibody ANX-M1 or IgG control, acute hippocampal slice LTP recordings, and an in vivo synaptic engulfment assay.
Limitations
- The paper states that specific synaptic C1q receptors are not yet known and that oAβ and C1q may act indirectly through cytokines such as TGFβ, microglial or astrocytic activation, or other pathways including MHCI/PirB.
- The paper states that the complement pathway may not be involved in all pathological routes to AD, including plaque-associated synapse loss, and that future studies are needed to examine plaque-associated synapse loss and other synaptopathies such as tauopathies and Huntington’s disease.
- Evident from the text: the findings are from mouse models and acute hippocampal slices, not human AD tissue or clinical trials, and the study focuses on early pre-plaque mechanisms rather than established plaque-associated neuropathology.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 2 Not checked · 48 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [5] Stevens B The classical complement cascade mediates CNS synapse elimination. Cell 2007 131 1164 1178 18083105 source
The Results report C1q localized to synapses in the developing dLGN during synaptic pruning and relocalized to adult retinal synapses in early glaucoma, before significant synapse loss. The Discussion likewise places synaptic C1q relocalization before or concurrent with synapse loss in the glaucoma model. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [27] Stephan AH Barres BA Stevens B The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci 2012 35 369 389 22715882 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“suggesting that the engulfed synapses are internalized into lysosomal compartments in a manner similar to developmental synaptic pruning (6).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [6] Schafer DP Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner. Neuron 2012 74 691 705 22632727 PMC3528177 source
The Results section, “Microglia engulf RGC inputs during a period of active synaptic pruning” (page unavailable), reports that most engulfed RGC inputs colocalized with microglial lysosomal compartments. The Results section, “Microglia engulf presynaptic elements specific to RGCs” (page unavailable), also identifies an RGC presynaptic marker within microglial lysosomes, supporting the proposed similarity to developmental synaptic pruning. (LLM, conf=0.94)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Quantification of colocalized pre- and postsynaptic puncta (synaptophysin and PSD95 (Fig. 1A); synaptotagmin and homer (figs. S1A-D)) revealed a significant loss of synapses in J20 hippocampus at 3-4 months old (mo), an age that precedes plaque deposition (11, 12).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [11] Mucke L High-Level Neuronal Expression of Abeta 1-42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation. Journal of Neuroscience 2000 20 4050 10818140 PMC6772621 source
The citation is attached to the statement that 3–4 months precedes plaque deposition, not to the citing authors’ synapse measurements. In “Effects of hAPP mutations on formation of amyloid plaques” (Fig. 4; page not provided), the paper assesses mice at 2–4 months and reports amyloid deposition in APP Sw,Ind mice at 5–7 months; the paper identifies J20 as an APP Sw,Ind line. (LLM, conf=0.91)
- Supportedcites [12] Hong S Dynamic Analysis of Amyloid -Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal A during Age-Related Plaque Formation. Journal of Neuroscience 2011 31 15861 15869 22049429 PMC3227224 source
The citation follows the statement that 3–4 months precedes plaque deposition, rather than the citing authors’ own synapse measurements. The Results section (page unavailable) identifies approximately 3-month-old J20 mice as pre-plaque and describes 3–7-month-old mice as plaque-free. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Genome-wide association studies (GWAS) implicate microglia and complement-related pathways in AD (1).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [1] Hong S Dissing-Olesen L Stevens B New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol 2016 doi:10.1016/j.conb.2015.12.004 PMC5479435 26745839 source
The Introduction says GWAS and integrated network studies identify immune-related AD risk pathways implicating microglia. The section on microglia–synapse dysfunction identifies GWAS variants CLU and CR1, both related to complement. Page numbers are not provided in our copy. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“C1q was also similarly increased in hippocampus of another model of AD, the APP/PS1 mice (15) (Fig. S2C).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [15] Jankowsky JL Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet 2004 13 159 170 14645205 source
The citation identifies the APP/PS1 mouse model, while the citing document points to its own Fig. S2C for the C1q increase. Figure 2 (p. 4) describes APPswe/PS1 double-transgenic mice and shows hippocampal amyloid pathology in that model. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
48 more claims · 5 with their cited sources checked
Create a free account to see all 66 claims and every source verdict.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“increasing evidence demonstrate that immune signaling may not just be a consequence of protein aggregation in the brain, but that it actually causes the buildup of aggregates at the earliest stages of the disease process.15–17”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In neurodegeneration, the complement pathway is activated, and inhibiting the complement proteins C1q or C3 results in less neuroinflammation, Aβ plaques and synapse loss29,30.”
From Exercise plasma boosts memory and dampens brain inflammation via clusterin (2021) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Before the onset of Aβ deposition, microglia engulf synapses opsonized with the complement factors C1q and C3 upon CR3-mediated recognition of C3 (121).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lack of C1q, C3, or CR3 curbed microglia activation and synaptic loss during amyloid plaque deposition.”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inappropriate control of the classical complement cascade causes unresolvable inflammation and disease (Hong et al. , 2016; Hansen, Hanson and Sheng, 2018; Morgan, 2018).”
From Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease (2020) · cites this paper as Hong et al., 2016
Experimental — accuracy not yet measured
70 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Cited work 10.1038/nn.3560 · retracted 2022-01-13 · notice 10.1038/s41593-021-00877-7 · this paper published 2016-05-06
Citations
Cites
1 retracted
Bialas, A. R., & Stevens, B. (2013) · Nature Neuroscience · doi:10.1038/nn.3560 · Cited by 519 · cited 2×
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Self-citationRetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Synaptic deficits occur in early AD and mild cognitively impaired patients before onset of plaques and are some of the first signs of the neuronal degenerative process (4, 23-25).”
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313 · cited 4×
“Although specific receptors for C1q at synapses are not yet known, C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
InfluentialSelf-citationIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 1×
“S11), indicating they are resident cells (22).”
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 3×
“S4), long before Aβ plaques deposit (11, 12), raising the question of whether C1q increase in these pre-plaque brains is dependent on soluble Aβ levels.”
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Cited by
Items 1,501–1,600 of 3,349
Haniff, Z. R., Bocharova, M., Mantingh, T., Rucker, J., Velayudhan, L., Taylor, D. M., Young, A. H., Aarsland, D., Vernon, A. C., & Thuret, S. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108641 · Cited by 22
Mesecar, M. E., Duffy, M. F., Acri, D. J., Ding, J., Langston, R. G., Shah, S. I., Nalls, M. A., Reed, X., Scholz, S. W., Whitaker, D. T., et al. (2026) · npj Aging · doi:10.1038/s41514-026-00391-9 · Cited by 30
Anderson, W. D., Greenhalgh, A. D., Takwale, A., David, S., & Vadigepalli, R. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00233 · Cited by 24
“Such simplified models are often considered to be desirable from the perspective of model analysis because model simplification facilitates the identification of critical regulators of the system’s function (Huang et al., 2010; Transtrum and Qiu, 2014).”
BackgroundTransneuronal Downregulation of the Premotor Cholinergic System After Corticospinal Tract Loss
Jiang, Y., Sarkar, A. D., Amer, A., & Martin, J. H. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.3410-17.2018 · Cited by 23
“These INs receive direct CST projections in mature rodents (Jiang et al., 2016), give rise to the cholinergic innervation (C bouton) on motoneurons (Zagoraiou et al., 2009), and modulate motoneuronal excitability through muscarinic type 2 receptors (Huang et al., 2000; Miles et al., 2007).”
BackgroundCao, M., MacDonald, J. W., Liu, H. L., Weaver, M., Cortes, M., Durosier, L. D., Burns, P., Fecteau, G., Desrochers, A., Schulkin, J. A., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01063 · Cited by 20
Schartz, N. D., Sommer, A. L., Colin, S. A., Méndez, L. B., & Brewster, A. L. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.112705 · Cited by 22
“In contrast, C1q-C3 hyperactivation is associated with aberrant neuronal circuitries as well as cognitive deficits in rodent models of Alzheimer’s disease (AD) [22].”
BackgroundLin, Z., Kim, E., Ahmed, M. U., Han, G., Simmons, C., Redhead, Y. T., Bartlett, J., Peña‐Altamira, E., Callaghan, I., White, M. A., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab114 · Cited by 30
Crowley, M. A., Garland, D. L., Sellner, H., Banks, A., Fan, L., Rejtar, T., Buchanan, N., Delgado, O., Xu, Y. Y., Jose, S., et al. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddac187 · Cited by 20
“Microglia CR3 activation plays a critical role in complement-dependent synapse pruning during brain development and in Alzheimer’s disease (28).”
BackgroundCircadian regulation of microglia function: Potential targets for treatment of Parkinson’s Disease
Kou, L., Chi, X., Sun, Y., Yin, S., Wu, J., Zou, W., Wang, Y., Jin, Z., Huang, J., Xiong, N., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102232 · Cited by 23
“Interestingly, complement-dependent synaptic pruning also follows a circadian rhythm, and microglial phagocytosis appears to play a central role in this process (Bodea et al., 2014; Rocha et al., 2015; Hong et al., 2016; Gregersen et al., 2021).”
Brain-Gut and Microbiota-Gut-Brain Communication in Type-2 Diabetes Linked Alzheimer’s Disease
Momen, Y. S., Mishra, J., & Kumar, N. (2024) · Nutrients · doi:10.3390/nu16152558 · Cited by 29
“…release a broad range of proinflammatory and toxic products such as reactive oxygen species, nitric oxide, and cytokines, resulting in neuroinflammation, and this is excessively engulfed through complement factors such as C1q and C3, resulting in neuronal loss and cognitive dysfunction [155,156].”
Liu, K., Fan, D., Wu, H., Hu, X., He, Q., Wu, X., Shi, C., Yang, J., & Ji, M. (2025) · Aging Cell · doi:10.1111/acel.70167 · Cited by 26
“Complement proteins, specifically C1q and C3, have been demonstrated to promote microglial engulfment of synaptic structures through the activation of the C3 receptor, thereby contributing to synapse loss in a mouse model of AD (Hong et al. 2016).”
Zhao, X., Yu, J., Xu, B., Xu, Z., Lei, X., Han, S., Luo, S., Zhang, C. M., Peng, G., Li, J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70331 · Cited by 31
“Among the principal pathways regulating synaptic plasticity regulation mediated by microglia, 37,56 our findings revealed that bEVs resulted in significant alterations in microglial C1q and CR3 expression, indicating an active involvement of bEVs in the C1q-C3-mediated synaptic pruning process.”
Mansour, G. K., Bolgova, O., Hajjar, A. W., & Mavrych, V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411843 · Cited by 25
“…medicine approaches utilizing vascular dysfunction indicators such as CSF PDGFR β levels [12,14,15], albumin quotient measurements [13,16], and complement activation markers [17–19] could enable early identification of at-risk individuals before classical pathological changes occur [76,77].”
Hammond, J. W., Qiu, W. Q., Marker, D. F., Chamberlain, J. M., Greaves‐Tunnell, W., Bellizzi, M. J., Lu, S., & Gelbard, H. A. (2018) · Glia · doi:10.1002/glia.23511 · Cited by 21
Antenatal Hypoxia Accelerates the Onset of Alzheimer’s Disease Pathology in 5xFAD Mouse Model
Shen, G., Hu, S. X., Zhao, Z., Zhang, L., & Ma, Q. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00251 · Cited by 21
C1q Regulates Horizontal Cell Neurite Confinement in the Outer Retina
Burger, C. A., Jiang, D., Li, F., & Samuel, M. A. (2020) · Frontiers in Neural Circuits · doi:10.3389/fncir.2020.583391 · Cited by 20
Strategies and Tools for Studying Microglial-Mediated Synapse Elimination and Refinement
Morini, R., Bizzotto, M., Perrucci, F., Filipello, F., & Matteoli, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.640937 · Cited by 26
“However, since the amount of complement proteins like C1q and C3 in FBS and BSA is not specified, it is not possible to infer the contribution of serum to beads phagocytosis (24, 103).”
BackgroundMethodStoiljković, M., Gutierrez, K. O., Kelley, C., Horváth, T. L., & Hajós, M. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210041 · Cited by 22
Lee, M. J., Wang, C., Carroll, M. J., Brubaker, D. K., Hyman, B. T., & Lauffenburger, D. A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.727784 · Cited by 21
“…from our study were validated in integrative computational AD literature and in literature oriented toward LOAD (Cribbs et al., 2012; Schafer et al., 2012; Zhang et al., 2013; Hong and Stevens, 2016; Hong et al., 2016; Keren-Shaul et al., 2017; Gratuze et al., 2018; Bartels et al., 2020).”
BackgroundFrancelle, L., & Mazzulli, J. R. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147798 · Cited by 23
van Zundert, B., & Montecino, M. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012081 · Cited by 21
“of PSD-95 is significantly reduced [137-139].”
BackgroundWiart, M., Tavakoli, C., Hubert, V., Hristovska, I., Dumot, C., Parola, S., Lerouge, F., Chauveau, F., Canet‐Soulas, E., Pascual, O., et al. (2022) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2022.109729 · Cited by 21
“Decreased microglial phagocytic activity also plays a role in the impaired clearance of beta-amyloid aggregates and thus in the progression of Alzheimer‟s disease (6).”
Molecular Regulation Mechanism of Microglial Autophagy in the Pathology of Alzheimer's Disease
Ou-Yang, P., Cai, Z., & Zhang, Z.-H. (2023) · Aging and Disease · doi:10.14336/ad.2023.0106 · Cited by 28
“production or the inhibition of C1q deposition ameliorate the oAβ-mediated microglial synaptic engulfment and synapse loss, implying the essential roles for complement and microglia in mediating synapse loss in AD [56].”
BackgroundDing, L.-L., Chu, W., Xia, Y., Ming, S., Li, T., Zhou, F., & Deng, D. Y. B. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06003-8 · Cited by 22
Lau, S., Fu, A. K. Y., & Ip, N. Y. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15933 · Cited by 24
Galectin‐3 is upregulated in frontotemporal dementia patients with subtype specificity
Borrego‐Écija, S., Pérez‐Millan, A., Antonell, A., Fort‐Aznar, L., Tilki, E. K., León‐Halcón, A., Lladó, A., Molina‐Porcel, L., Balasa, M., Juncà‐Parella, J., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13536 · Cited by 22
“64 We also demonstrated a positive relationship between CSF Gal-3 levels and t-tau in AD patients along with GAP-43 and neurogranin,markersofsynapticdysfunction.”
BackgroundYe, L., Hu, M., Mao, R., Yi, T., Sun, M., Jia, J., Xu, S., Liu, Y., Zhu, X., Xu, Y., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14555 · Cited by 26
“13 Treatment with the metabotropic glutamate receptor 5 (mGluR5) silent allosteric modulator BMS-984923 re - versed these changes.”
BackgroundShim, K. H., Kim, D., Kang, M. J., Pyun, J., Park, Y. H., Youn, Y. C., Park, K. W., Suk, K., Lee, H., Gomes, B. F., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13734 · Cited by 22
“8 Although the role of complement C3 in AD is controversial, the final consequence would be determined by the balance of complement activation and inhibition, and the disturbance of this balance could lead to neuroinflammation and disease progression.”
BackgroundEvidence that Alzheimer’s Disease Is a Disease of Competitive Synaptic Plasticity Gone Awry
Huang, Z. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240042 · Cited by 21
“For example, the complement cascade and receptors are well known to play a prominent role in activity-dependent axon/synapse competition [255–257], by recognizing as well as being activated by PS in this process [32, 33].”
Current understanding on TREM-2 molecular biology and physiopathological functions
Bharadwaj, S., Groza, Y., Mierzwicka, J. M., & Malý, P. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112042 · Cited by 25
Lu, B.-L., Li, J., Zhou, J., Li, W., & Wu, H.-F. (2016) · Neuroreport · doi:10.1097/wnr.0000000000000618 · Cited by 21
Pearce, M. M. P. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.03.011 · Cited by 21
Tau Spread, Apolipoprotein E, Inflammation, and More
Gonzalez, B. L., Abud, E. M., Abud, A. M., Poon, W. W., & Gylys, K. H. (2017) · Neurologic Clinics · doi:10.1016/j.ncl.2017.01.001 · Cited by 20
A Rational Structured Epitope Defines a Distinct Subclass of Toxic Amyloid-beta Oligomers
Silverman, J. M., Gibbs, E., Peng, X., Martens, K. M., Balducci, C., Wang, J., Yousefi, M., Cowan, C. M., Lamour, G., Louadi, S., et al. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00469 · Cited by 23
Genomics: New Light on Alzheimer’s Disease Research
Jung, Y. J., Kim, Y. H., Bhalla, M., Lee, S. B., & Seo, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123771 · Cited by 21
“One recent study demonstrated that up-regulation of C1q (an “eat-me” signal) in the AD brain can be attributed to increased synapse elimination by microglia [118].”
BackgroundImbalance in the response of pre- and post-synaptic components to amyloidopathy
Stephen, T., Tamagnini, F., Piegsa, J., Sung, K., Harvey, J., Oliver‐Evans, A., Murray, T. K., Ahmed, Z., Hutton, M. L., Randall, A. D., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50781-1 · Cited by 25
Many Faces of TRIM Proteins on the Road from Pluripotency to Neurogenesis
Nenasheva, V. V., & Tarantul, V. Z. (2019) · Stem Cells and Development · doi:10.1089/scd.2019.0152 · Cited by 21
“Their deposition in synapses seems to cause the memory loss in AD [145].”
Impact of New Drugs for Therapeutic Intervention in Alzheimer’s Disease
Olloquequi, J., Ettcheto, M., Cano, A. C., Sánchez‐López, E., Carrasco, M., Espinosa-Jiménez, T., Beas‐Zárate, C., Gudiño‐Cabrera, G., Ureña‐Guerrero, M. E., Verdaguer, E., et al. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2705146 · Cited by 27
“Microglia are CNS-resident phagocytes that play a vital role in maintaining neuronal plasticity and synapse re-modeling [84,85].”
BackgroundOrdóñez‐Gutiérrez, L., Benito‐Cuesta, I., Abad, J. L., Casas, J., Fabriàs, G., & Wandosell, F. G. (2018) · Pharmaceutical Research · doi:10.1007/s11095-017-2312-2 · Cited by 20
Tzioras, M., Daniels, M. J. D., Davies, C., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/795930 · Cited by 20
Is Alzheimer’s disease a polymicrobial host microbiome dysbiosis?
Singhrao, S. K., & Harding, A. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1729741 · Cited by 24
Pisani, F., Pisani, V., Arcangeli, F., Harding, A., & Singhrao, S. K. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20116049 · Cited by 23
Zhao, Y., Guo, Q., Tian, J., Liu, W., & Wang, X. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102596 · Cited by 26
Agrawal, S., Yu, L., Leurgans, S. E., Nag, S., Barnes, L. L., Bennett, D. A. A., & Schneider, J. A. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14500 · Cited by 23
“…studies have shown that pathologic aggregates can act as a stressor to induce a plethora of cytotoxic mechanisms including upregulation in reactive oxygen species level, 27 synaptic dysfunction, 28 inflammation, 29 and mitochondrial dysfunction, 30 ultimately terminating in neuronal cell death.”
Alzheimer’s disease and age-related macular degeneration: Shared and distinct immune mechanisms
Butovsky, O., & Rosenzweig, N. (2025) · Immunity · doi:10.1016/j.immuni.2025.04.013 · Cited by 22
Laabi, S., LeMmon, C., Vogel, C., Chacon, M., & Jimenez, V. M. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114940 · Cited by 23
Multicellular hypothesis for the pathogenesis of Alzheimer's disease
Goetzl, E. J., & Miller, B. L. (2017) · The FASEB Journal · doi:10.1096/fj.201601221r · Cited by 20
Zuo, Z., Qi, F., Xing, Z., Yuan, L., Yang, Y., He, Z., Zhou, L., & Yao, Z. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.01.001 · Cited by 19
Regulation of phospholipid dynamics in brain
Maruoka, M., & Suzuki, J. (2021) · Neuroscience Research · doi:10.1016/j.neures.2021.01.003 · Cited by 21
Isoform-dependent APOE secretion modulates neuroinflammation
Hasel, P., & Liddelow, S. A. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00483-y · Cited by 22
Tang, M.-Y., Gorin, F. A., & Lein, P. J. (2022) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2022.05 · Cited by 25
“In Alzheimer mouse models, early synaptic loss is associated with C1q complement tightly bound to AB plaques surrounded by neuronal atrophy from microglial phagocytosis[29].”
BackgroundThe Dual Nature of Microglia in Alzheimer’s Disease: A Microglia-Neuron Crosstalk Perspective
Xie, Z., Meng, J., Wu, Z., Nakanishi, H., Hayashi, Y., Kong, W., Lan, F., Narengaowa, Yang, Q., Qing, H., et al. (2023) · The Neuroscientist · doi:10.1177/10738584211070273 · Cited by 19
Zhou, Y., Liu, X., Ma, S., Zhang, N., Yang, D., Wang, L., Ye, S., Zhang, Q., Ruan, J., Ma, J., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202101625r · Cited by 20
Leinenga, G., Bodea, L., Schröder, J., Sun, G., Zhou, Y., Song, J. H., Grubman, A., Polo, J. M., & Götz, J. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10329 · Cited by 19
“Indeed, microglia have been observed to remove synapses in AD through a mechanism involving members of the complement system.(37,38) In addition, it has been proposed that the metabolism of microglia is impaired in AD, an effect that can be ameliorated by enhancing the cellular energetic and biosynthetic metabolism.”
BackgroundNovel Anti-Neuroinflammatory Properties of a Thiosemicarbazone–Pyridylhydrazone Copper(II) Complex
Choo, X. Y., McInnes, L. E., Grubman, A., Wasielewska, J. M., Belaya, I., Burrows, E. L., Quek, H., Cañas-Martín, J., Loppi, S. H., Sorvari, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810722 · Cited by 20
Pomilio, A. B., Vitale, A. A., & Lazarowski, A. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666221003101548 · Cited by 20
Single-cell RNA sequencing identifies hippocampal microglial dysregulation in diet-induced obesity
Henn, R. E., Guo, K., Elzinga, S. E., Noureldein, M. H., Mendelson, F. E., Hayes, J. M., Rigan, D. M., Savelieff, M. G., Hur, J., & Feldman, E. L. (2023) · iScience · doi:10.1016/j.isci.2023.106164 · Cited by 20
“Microglia upregulate C1q in response to insult such as ischemic injury(58) or in amodel of Alzheimer’s disease.(59) The complement cascade’s canonical role is in immune response, but complement is also involved in microglial mediated synaptic pruning in brain development.”
BackgroundClassification of Alzheimer's disease using robust TabNet neural networks on genetic data
Jin, Y., Ren, Z., Wang, W., Zhang, Y., Zhou, L., Yao, X., & Wu, T. (2023) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2023366 · Cited by 25
Hindley, N., Avila, A. S., & Henstridge, C. M. (2023) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2023.1130198 · Cited by 22
“…proteins from the complement system, an innate immune response pathway, are elevated in the brains of patients with various neurodegenerative diseases and this pathway may be a major player in glial phagocytosis of synapses (Hong et al., 2016; Gomez-Arboledas et al., 2021; Fatoba et al., 2022).”
BackgroundRahman, K. A., Orlando, M., Boulos, A., Andrzejak, E., Schmitz, D., Ziv, N. E., Prüß, H., Garner, C. C., & Ichkova, A. (2023) · Glia · doi:10.1002/glia.24369 · Cited by 25
“Within the CNS, microglia perform several important functions including synaptic pruning during development (Schafer et al., 2012) and degenerative disorders like Alzheimer's Disease (Hong et al., 2016).”
BackgroundResultInfluentialYe, L., Shu, S., Jia, J., Sun, M., Xu, S., Bao, X., Bian, H., Liu, Y., Zhang, M., Zhu, X., et al. (2023) · Aging Cell · doi:10.1111/acel.13860 · Cited by 20
“Synaptic loss is a major pathological event in aging- associated cognitive decline and neurodegenerative diseases (Hong et al., 2016; Pannese, 2011).”
BackgroundInfluentialNeuroinflammation: The Abused Concept
Galea, E., & Graeber, M. B. (2023) · ASN NEURO · doi:10.1177/17590914231197523 · Cited by 22
“…inflammasome and amyloid-β plaque seeding (Venegas et al., 2017) and propagation (d’Errico et al., 2022), phagocytosis and secretion of amyloid-β fibers (Huang et al., 2021), defective phagocytosis of amyloid-β via TREM2 (Ulland & Colonna, 2018), excessive phagocytosis as in synaptic pruning (Hong…”
BackgroundTreatment of geographic atrophy: an update on data related to pegcetacoplan
Patel, S. B., Heier, J. S., Chaudhary, V., & Wykoff, C. C. (2023) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000845 · Cited by 23
“C3b and its fragments have been demonstrated to promote Volume 35 (cid:1) Number 1 (cid:1) January 2024 phagocytosis by macrophages and microglia [27,28].”
BackgroundWang, Q., Ruan, Z., Jing, L., Guo, Z., Zhang, X., Liu, J., Tian, L., Sun, W., Song, S., Hong, J., et al. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115550 · Cited by 22
Mo, H., Kim, J., Kim, J. Y., Kim, J. W., Han, H., Choi, S. H., Rim, Y. A., & Ju, J. H. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00384-8 · Cited by 22
“Astrocytes in AD are known to have reduced expression of synaptic proteins, suggesting an excessive immune response, in contrast to healthy astrocytes that protect against synapse loss [38, 39].”
BackgroundRodriguez‐Rodriguez, P., Arroyo‐García, L. E., Tsagkogianni, C., Li, L., Wang, W., Végvári, Á., Salas-Allende, I., Plautz, Z., Cedazo-Mínguez, Á., Sinha, S. C., et al. (2024) · Brain · doi:10.1093/brain/awae051 · Cited by 19
“52,53,67,68 While we also found increased expression of Tyrobp and Spp1 , both upregulated in disease-associated microglia in AD, 54,55,69 a more comprehensive analysis of gene expression changes at single cell resolution will be necessary to determine which microglia states are triggered by Dek…”
BackgroundZhu, L., Mao, K., Liu, L., Xu, S., Zeng, M., Fu, Y., Huang, J., Li, T., Gao, G., Teng, Z., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113964 · Cited by 25
What the Spectrum of Microglial Functions Can Teach us About Fetal Alcohol Spectrum Disorder
Wong, E. L., Stowell, R. D., & Majewska, A. K. (2017) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2017.00011 · Cited by 22
“Thus, a mechanism of synapse regulation from development can become pathological when reactivated later in life, leading to progression of a neurodegenerative disease such as Alzheimer’s (Hong et al., 2016).”
BackgroundInfluentialByun, Y. G., & Chung, W. (2018) · Journal of Visualized Experiments · doi:10.3791/56647 · Cited by 26
Cloarec, R., Bauer, Š., Teissier, N., Schaller, F., Luche, H., Courtens, S., Salmi, M., Pauly, V., Bois, E., Pallesi‐Pocachard, E., et al. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00055 · Cited by 21
“…used in a range of models for various postnatal neurological insults and disorders, such as neonatal excitotoxic brain damage (Dommergues et al., 2003), experimental autoimmune encephalitis (Ponomarev et al., 2011), cerebral palsy (Kannan et al., 2012), or Alzheimer disease (Hong et al., 2016).”
BackgroundSocial housing promotes cognitive function through enhancing synaptic plasticity in APP/PS1 mice
Liang, F., Shen, Y., Zhang, Y., & Hao, T. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.111910 · Cited by 21
Kuroda, E., Takata, K., Nishimura, K., Oka, H., Sueyoshi, M., Aitani, M., Kouda, A., Satake, S., Shima, C., Toda, Y., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190974 · Cited by 20
Chen, X., Das, U., Park, G., & Mobley, W. C. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00796-6 · Cited by 20
Effect of memantine, an anti-Alzheimer’s drug, on rodent microglial cells in vitro
Murakawa‐Hirachi, T., Mizoguchi, Y., Ohgidani, M., Haraguchi, Y., & Monji, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-85625-4 · Cited by 20
Luckey, A. M., Robertson, I. H., LAWLOR, B. A., Mohan, A., & Vanneste, S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210404 · Cited by 25
Kaurani, L., Islam, M. R., Heilbronner, U., Krüger, D. M., Zhou, J., Methi, A., Strauss, J., Pradhan, R., Schröder, S., Burkhardt, S., et al. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00067-8 · Cited by 17
“Moreover, aberrant microglia activation and synaptic pruning is observed in neurodegenerative diseases such as Alzheimer ’ s disease (Hong et al, 2016), and ZBP1 also controls the NRLP3 in fl ammasome (Kuriakose et al, 2016), a key regulator of neuroin fl ammatory phenotypes in Alzheimer ’ s disease…”
Mo, S., Shi, C., Cai, Y., Xu, M., Xu, H., Xu, Y., Zhang, K., Zhang, Y., Liu, J., Che, S., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1387808 · Cited by 19
Peng, M., Zou, R., Yao, S., Meng, X., Wu, W., Zeng, F., Chen, Z., Yuan, S., Zhao, F., & Liu, W. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122871 · Cited by 20
Wu, Y., Yang, L., Jiang, W., Zhang, X., & Yao, Z. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00190 · Cited by 23
Wang, F., Liang, Y., & Wang, Q. (2024) · Scientific Reports · doi:10.1038/s41598-024-80401-6 · Cited by 27
“Previous research has demonstrated that the complement system and microglia contribute to early synaptic deficits in AD mouse models 23 .”
Astrocyte-Synapse Structural Plasticity in Neurodegenerative and Neuropsychiatric Diseases
Badia‐Soteras, A., Mak, A., Blok, T. M., Boers-Escuder, C., van den Oever, M. C., Min, R., Smit, A. B., & Verheijen, M. H. G. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.04.011 · Cited by 23
Complement therapeutics in neurodegenerative diseases
Zelek, W. M., & Tenner, A. J. (2025) · Immunobiology · doi:10.1016/j.imbio.2025.153089 · Cited by 21
“In AD, C1q also binds synapses, both prior to and after A β plaque deposition, and in the presence of the other early pathway components activates the CP tagging synapses for elimination (Hong et al., 2016; Shi et al., 2017; Gomez-Arboledas et al., 2024).”
Effects of exercise on neuroinflammation in age-related neurodegenerative disorders
Su, Y., & Su, Z. (2025) · European journal of medical research · doi:10.1186/s40001-025-03165-3 · Cited by 26
“However, it is more probable that it plays a crucial part in the initial phases of the illness by aiding in the creation of these groupings [37–39].”
Li, M., Chen, S., Guo, R., Wang, Y., Yang, M., Liu, Y., Zhang, Q., Zhu, S., Li, J., Chen, F., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02453-y · Cited by 27
“29, 30).”
Wang, X., Xu, Z., Zhao, F., Lin, K. J., Foster, J. B., Xiao, T., Kung, N., Askwith, C. C., Bruno, J. P., Valentini, V., et al. (2020) · Neurobiology of Stress · doi:10.1016/j.ynstr.2020.100240 · Cited by 18
“E) (Hong et al., 2016).”
Idrissi, F. E., Gressier, B., Devos, D., & Bélarbi, K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.630003 · Cited by 22
“…and ITGAM (also named CD11b, one protein subunit that forms macrophage antigen complex-1 (Mac-1) or complement receptor 3 (CR3)) that stimulation by amyloid beta leads to microglia activation, resulting in increased cytokine production and oxidative stress (Hong et al., 2016; Yang et al., 2020).”
BackgroundCX3C-chemokine receptor 1 modulates cognitive dysfunction induced by sleep deprivation
Xin, J., Wang, C., Cheng, X., Xie, C., Zhang, Q., Ke, Y., Huang, X., Chen, X., & Pan, X. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001769 · Cited by 21
“A previous study showed that the inhibition of microglial overactivation significantly reduced the extent of early synapse loss in adult AD mice.([45]) Yang et al([46]) also found that after learning different skills, new dendritic spines appeared in mice.”
BackgroundKey brain cell interactions and contributions to the pathogenesis of Alzheimer’s disease
Saavedra, J., Nascimento, M., Liz, M. A., & Cardoso, I. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1036123 · Cited by 16
“microglial complement receptor CR3, decrease the number of phagocytic microglia and the amount of early synapse loss, implying that complement activation may be an early modulator of plaque-associated synapse loss in AD by activating phagocytic microglia (Hong et al., 2016).”
BackgroundSmall-molecule screen reveals pathways that regulate C4 secretion in stem cell-derived astrocytes
Rapino, F. A., Natoli, T. E., Limone, F., O’Connor, E., Blank, J., Tegtmeyer, M., Chen, W., Norabuena, E. M., Narula, J. G., Hazelbaker, D. Z., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.11.018 · Cited by 22
“Although the inhibition of complement is recognized as a potentially valuable therapeutic approach, developing useful clinicalCNS complement-inhibitingdrugshas been challenging, due to the limited permeability of the blood-brain barrier (BBB) (Ricklin and Lambris, 2016), although antibodies that block C1q can lessen m…”
BackgroundInfluentialSelf-citationThe β‐adrenergic hypothesis of synaptic and microglial impairment in Alzheimer's disease
Li, S. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15782 · Cited by 19
“The protective effects of β2- AR agonists were attributed to increasing Ca 2+ influx through spine- localized L- type VDCCs (Hoogland & Saggau, 2004; Qian et al., 2017), to enhancing LTP at synapses (Yasuda et al., 2003), and to increasing neurogenesis and spine density (Chai et al., 2016).”
BackgroundSelf-citationThe complement inhibitor CD59 is required for GABAergic synaptic transmission in the dentate gyrus
Wen, L., Yang, X., Wu, Z., Fu, S., Zhan, Y., Chen, Z., Bi, D., & Shen, Y. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112349 · Cited by 20
Wang, Y., Zhao, T., Jiao, Y., Huang, H., Zhang, Y., Fang, A., Wang, X., Zhou, Y., Gu, H., Wu, Q., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202203051 · Cited by 19
Wu, Y., Xu, D., He, Y., Yan, Z., Liu, R., Liu, Z., He, C., Liu, X., Yu, Y., Yang, X., et al. (2023) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0011350 · Cited by 22
“A previous study report that, besides magnifying inflammation, microglia is capable of phagocyting synapse components via complement-dependent pathways in the early of the disease [71].”
BackgroundWang, G., Jin, S., Liu, J., Li, X., Dai, P., Wang, Y., & Hou, X. S. (2023) · National Science Review · doi:10.1093/nsr/nwad222 · Cited by 21
“S2D), suggesting that they were not activated to engulf synaptic material as previously described in Alzheimer mouse models [24 ].”
Phenomic Microglia Diversity as a Druggable Target in the Hippocampus in Neurodegenerative Diseases
Lana, D., Magni, G., Landucci, E., Wenk, G. L., Pellegrini-Giampietro, D. E., & Giovannini, M. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813668 · Cited by 20
Pradhan, A. K., Neumüller, T., Klug, C., Fuchs, S., Schlegel, M., Ballmann, M., Tartler, K. J., Pianos, A., Garcia, M. S., Lière, P., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02630-z · Cited by 23
Schartz, N. D., Aroor, A., Li, Y., Pinzón-Hoyos, N., & Brewster, A. L. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1265944 · Cited by 18
“Similarly, drug-mediated inhibition or ablation of C3 signaling prevented or attenuated memory decline in experimental models of autoimmune encephalomyelitis (Hammond et al., 2020), West Nile virus infection (Vasek et al., 2016), and AD (Hong et al., 2016; Shi et al., 2017).”
BackgroundBellio, T. A., Laguna-Torres, J. Y., Campion, M. S., Chou, J., Yee, S., Blusztajn, J. K., & Mellott, T. J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297289 · Cited by 22
Crowley, M. A., Delgado, O., Will-Orrego, A., Buchanan, N. M., Anderson, K., JAFFEE, B. D., Dryja, T. P., & Liao, S.-M. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-22605 · Cited by 18
Modeling Alzheimer’s disease brains in vitro
Henstridge, C. M., & Spires‐Jones, T. L. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0177-2 · Cited by 20
Metadata
- Authors
- Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., Lemere, C. A., Selkoe, D. J., & Stevens, B.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- University of California, San Francisco (US)
- Stanford Medicine (US)
- Broad Institute (US)
- Corresponding author
- Beja-Glasser, Victoria F.
- Nfonoyim, Bianca M.
- Stevens, Beth
- ORCID
- Venue
- Science
- Published
- 2016-05-06
- Volume
- 352
- Issue
- 6286
- Pages
- 712-716
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5094372
- OpenAlex
- W2314634699
- Cited by
- 3,343
- References
- 33
- Citations by year
- 2026: 415 · 2025: 391 · 2024: 384 · 2023: 388 · 2022: 324 · 2021: 363 · 2020: 306 · 2019: 260 · 2018: 240 · 2017: 198 · 2016: 69
- FWCI
- 140.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Edward R. and Anne G. Lefler Fellowship
- Coins for Alzheimer's Research Trust
- Fidelity Biosciences Research Initiative
- JPB Foundation
- National Institutes of Health (AG000222)
- National Institute of Neurological Disorders and Stroke-NIH (R01NS083845)
- National Institute on Aging-NIH (1RF1AG051496A)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, synaptic loss, complement system, microglia, C1q, CR3, complement C3, soluble amyloid-beta oligomers, neuroinflammation, synaptic pruning, hippocampal long-term potentiation, phagocytosis, mouse model
- MeSH terms
- Disks Large Homolog 4 Protein, Alzheimer Disease, Animals, Cognition Disorders, Complement Pathway, Classical, Disease Models, Animal, Membrane Proteins, Phagocytosis, Synapses, Up-Regulation, Complement C1q, Macrophage-1 Antigen, Amyloid beta-Peptides, Synaptophysin, Microglia, Long-Term Potentiation, Mice, Knockout, Mice, Guanylate Kinases, CA1 Region, Hippocampal, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.